PRAX
$4.64
Praxis Precision Medicines
($.15)
(3.13%)
PRAX
Earnings Whisper ®
N/A
4th Quarter December 2022
Consensus:  ($0.73)
Revenue:  N/A
Monday
Feb 27
4:00 PM ET
Score
Grade
Tweet Share Watch
Tweet Share Watch

What do you expect when PRAX reports earnings?
Beat
Meet
Miss

Where is PRAX's stock price going from here?
Up
Flat
Down
Stock chart of PRAX
Analysts
Summary of analysts' recommendations for PRAX
Score
Grade
Pivots
Resistance
$5.35
$5.19
$4.91

$4.75

Support
$4.47
$4.31
$4.03
Tweet
Growth
Description
Praxis Precision Medicines Inc. is a clinical-stage biopharmaceutical company translating genetic insights into the development of therapies for central nervous system disorders characterized by neuronal imbalance. Praxis Precision Medicines Inc. is based in CAMBRIDGE, Mass.